Anaphylaxis
Publication Date: December 17, 2023
Key Points
Key Points
- Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a wide range of clinical manifestations.
- Severe anaphylaxis and/or the need for repeated doses of epinephrine to treat anaphylaxis are risk factors for biphasic anaphylaxis.
- Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.
Diagnosis
...agnosis...
...Joint Task Force suggests that a c...
...Joint Task Force suggests extended...
Treatment
...eatmen...
...Force suggests against administering gluco...
...Force suggests in favor of administerin...
...e Joint Task Force suggests against routinely a...
...k Force suggests in favor administerin...
...actice Statements...
...r epinephrine as the first-line phar...
...delay the administration of epine...
...osis and treatment of anaphylaxis,...
...nts with anaphylaxis should receive education...
...ested Key Clinical Advi...
...Severe anaphylaxis and/or the need...
...llustration...